DM

Showing posts with label Technique. Show all posts
Showing posts with label Technique. Show all posts

Friday, July 19, 2013

Superficial Radiotherapy vs Conventional Medical Technique

If you are fighting cancer, you often will have a choice to create on whether you are going to go for Trivial Radiotherapy (SRT) or the Conventional Medical Strategy. Both surgery treatment and SRT are efficient in their own regard but have benefits and drawbacks and it is essential that you know what exactly you are getting yourself into before you create your choice.

There are a number of key components that you need to take into consideration when creating this big choice. Keep in thoughts that both Trivial Radiotherapy and Surgery are cancer therapies that implement quite different methods. Below are some of the things you may want to know:

What Place is Being Treated?

SRT and surgery treatment are each used to cure cancer on different places in the human body. Trivial radiotherapy is mainly depended upon when dealing with cancer on the experience or locations where there are some marks you would like to get rid of. SRT generally snacks 'superficial' cancer, which indicates surface area or light cancer.

Succinctly circumstances of inner cancer are almost difficult to get handled by superficial radiotherapy. Such circumstances guarantee for the use of surgery treatment. Surgery may also be your best bet of throwing cancer out of your life if the cancer is very serious.

Therefore if you really want to go for superficial radiotherapy, it is essential not to hang on anymore because the more intense your scenario gets the less likely SRT will help you. But if you are not really sure which skin cancer treatment is best for you, going for a assessment with a certified doctor can help you create a careful choice.

Side Results

Scarring, attacks, cancer repeat and the need for overall look renovation are all possible adverse reactions when surgery treatment is engaged. Surgery includes creating cuts and generally reducing out the cancer until there is no more cancer tissues remaining on the area. The issue with this procedure is it is likely to cause scarring damage and a renovation will definitely be unavoidable.

Superficial Radiotherapy however may outcome to inflammations, paleness and reddening of the handled area. One of the benefits about it is these effects will progressively cure with time. However there are circumstances where SRT results in long lasting locks reduction or staining of the epidermis.

As far are these adverse reactions are engaged, you should give regard to the area you need treatment on when creating your choice. If the area is likely to be poorly suffering from frightening for example like the experience, then surgery treatment is not a appropriate choice for you.

Costs of Treatment

Surgical skin cancer treatment will always be costly than superficial radiotherapy. This is because the price of surgery treatment will include the surgeon's charges, expenses of surgery features, expenses of post-treatment medicines and sedation charges. These are additional expenses that will not actually be suffered during superficial radiotherapy.

SRT on the common expenses $1500 and is consequently the most affordable skin cancer treatment you will find around. But based on what your economical limits are and what your price range can allow you should be able to choose which the best options is for you.

These are the top 3 aspects that everyone who is yet to determine which technique to use should think about. With this details in thoughts, it is quite easy to create a good verdict and take price of your health's position from a more advised perspective.


View the original article here

Sunday, July 7, 2013

New Technique Developed To Track Cell Interactions In Living Bodies

Main Category: Cancer / Oncology
Also Included In: Biology / Biochemistry
Article Date: 08 May 2013 - 1:00 PDT Current ratings for:
New Technique Developed To Track Cell Interactions In Living Bodies
not yet ratednot yet rated
Researchers at Stanford University School of Medicine have developed a new technique to see how different types of cells interact in a living mouse. The process uses light-emitting proteins that glow when two types of cells come close together.

Using the technique, the team was able to pinpoint where in the body metastatic cancer cells ended up after they broke off from an initial tumor site, using readily available lab reagents. The team chose chemicals that are easily available in most life sciences laboratories because they wanted to develop a technique that could be widely used.

The study was published online in the Proceedings of the National Academy of Sciences.

Until now, the best way to see cells interacting inside a living animal or person was to implant a microscope. But predicting all the places metastatic cancer cells will proliferate is nearly impossible. "There are currently no great ways to look at early metastasis, where metastases are finding their micro-environments and setting up shop," said Mark Sellmyer, MD, PhD, the study's lead author, who developed the technique as a graduate student working jointly for Christopher Contag, PhD, professor of pediatrics and of microbiology and immunology, and Tom Wandless, PhD, associate professor of chemical and systems biology.

Sellmyer, who begins a research residency in radiology at the University of Pennsylvania this summer, worked closely with Jennifer Prescher, PhD, a former postdoctoral scholar in Contag's lab who is now an assistant professor at the University of California-Irvine. "I think it really expands our capabilities, expands the tool box," Prescher said. "We're always beholden to the tools available for us in terms of what we can observe. Any time we have a new vantage point - a new technology - it can open doors to understanding new aspects of biology."

Sellmyer and Prescher genetically altered immune cells and cancer cells - what they call activator and reporter cells, respectively - so the cells would produce two different enzymes. The activator immune cells created the enzyme B-galactosidase, which can convert a common biological probe called a "caged luciferin" into luciferin, a molecule naturally found in animals like fireflies. The reporter cancer cells created the enzyme luciferase, which splits the luciferin molecule in a chemical reaction that emits light.

After demonstrating the process could work in a cell culture in a petri dish, they used the same method in living mice. The mice were implanted with genetically altered bone marrow cells that generated activator immune cells. An experimental group of 10 mice had tumors made of cancer cells genetically altered to serve as reporters implanted into their abdomens. For comparison, a control group of four additional mice were implanted with unaltered bone marrow cells. After several weeks, the researchers injected a compound that would be converted to light-emitting luciferin.

The researchers could easily see where populations of immune cells got close to metastatic cancer cell populations because those parts of the mouse body would glow and take a picture of the pattern of light emitted by the mouse's body. Among other metastasis sites, researchers were surprised to find that in several mice, small populations of cancer cells had started to grow in their noses and just under their lower jaws.

Currently, the technique can't be used in people, but the researchers hope it will be used to study a variety of cell interactions in laboratory mice. Contag is planning to use the technique to study how immune cells migrate to sites of infection. Cell-cell communication is important for a variety of biological processes," he said. "Knowing the proximity of one cell type to another in the context of the living tissue is key for understanding biology."

The technique requires a minimum population of 1,000 cells for both the activator and reporter cells to work. Prescher is working on improving the precision of the method so that smaller populations with fewer cells can be tracked.

Both Contag and Wandless noted that Sellmyer's and Prescher's interdisciplinary approach was key to developing the technique. "Their training in biology allowed them to identify an important problem in the area of in vivo imaging, and their ability to incorporate chemistry allowed Mark and Jenn to design and develop a new technique that would be out-of-reach to the majority of classical biology labs," Wandless said.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject. Other Stanford authors of the study include postdoctoral scholar Laura Bronsart, PhD, and visiting scholar Hiroshi Imoto, PhD.

The study was supported by the National Institutes of Health (grants GM073046 and P50CA114747), the NIH Medical Scientist Training Program and the Susan G. Komen Foundation.

Stanford University Medical Center

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Stanford University Medical Center. "New Technique Developed To Track Cell Interactions In Living Bodies." Medical News Today. MediLexicon, Intl., 8 May. 2013. Web.
13 May. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'New Technique Developed To Track Cell Interactions In Living Bodies'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here